Effects of Antiviral Therapies on Epstein-Barr Virus Replication
Status:
ENROLLING_BY_INVITATION
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
This research study is being performed to find out if Truvada (tenofovir/emtricitabine), an antiviral drug with activity against the Epstein Barr virus (EBV), can reduce EBV levels in saliva and blood in people with multiple sclerosis (MS). A second goal is to find out if Truvada (tenofovir/ emtricitabine) is safe and tolerable in people with MS.
Phase:
PHASE2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Solving MS
Treatments:
Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir